RTI Biologics, Inc.

Board of Directors

» Learn more about RTI's Board Committees

 

Brian K. HutchisonBrian K. Hutchison

Brian Hutchison was named chairman and chief executive officer for RTI Biologics in February 2008. He joined RTI in December 2001 as president and CEO and was elected chairman of the board of directors in December 2002.

In his role at RTI, Hutchison oversees all aspects of the company and its affiliates. He serves on the board of directors for the United Way of North Central Florida.

Hutchison spent the previous 12 years with Stryker Corporation, based in Kalamazoo, Mich. He served most recently as vice president, worldwide product development and distribution.

A native of Muskegon, Mich., Hutchison earned a bachelor’s degree in business administration from Grand Valley State University in 1981. He also completed the Program for Management Development from Harvard Business School in 1995.

Back to top Back to top

Guy L. MayerGuy L. Mayer

Guy Mayer was named president for RTI Biologics in February 2008. He joined Tutogen Medical as president and chief executive officer in January 2005. In his role at RTI Biologics, Mayer oversees all aspects of marketing and distribution through medical device companies.

Prior to Tutogen, Guy served for two years as chairman and CEO of Visen Medical, a private biotech company focused on Molecular Imaging technologies. Prior to Visen, he served three years as president and CEO of ETEX Corporation, a private biomedical company based in Cambridge, Mass. For 13 years prior to joining ETEX, Mayer held various senior positions at Zimmer Inc., then a division of Bristol Myers Squibb, with sales in excess of $1.2 billion.

Guy is a graduate of the University of Ottawa and currently serves on the Board of Directors of Spire Corporation, a public company, as well as a number of private companies.

Back to top Back to top

Julianne M. BowlerJulianne M. Bowler

Julianne M. Bowler joined RTI's Board of Directors in May 2007. Bowler served as commissioner of insurance for the Massachusetts Division of Insurance, based in Boston, Mass, from March 2002 to January 2007. She has more than 10 years of experience in insurance regulation and health policy for companies such as Blue Cross Blue Shield of Massachusetts and the University of Massachusetts Medical Center, including 9 years with the Massachusetts Division of Insurance. Bowler has a bachelor’s degree in philosophy from Assumption College in Worcester, Mass., and a master’s degree in philosophy from the University of Dallas in Dallas, Tex. She was a doctoral candidate in biomedical ethics at Georgetown University in Washington, D.C., and received her master’s degree in business administration with a concentration in finance from the University of Massachusetts in Boston, Mass.

Back to top Back to top

Phillip R. ChapmanPhillip R. Chapman

Phillip R. Chapman has served as a member of RTI's Board of Directors since February 1998. He is the president of Venad Administrative Services, Inc. and has been a general partner of Adler & Company since 1995. From 1991 until 1995, he served as a principal of Adler & Company. From 1981 until 1989, Chapman served as a senior consultant at Booz Allen & Hamilton International. Chapman is also a director of Shells Seafood Restaurants, Inc. He holds a bachelor's degree and masters of business administration degree from Columbia University.

Back to top Back to top

Roy D. Crowninshield, PH.D.Roy D. Crowninshield, PH.D.

Roy D. Crowninshield, PH.D. served as the Interim Chief Executive Officer of Tutogen Medical, Inc. from July 2004 to December 2004. Prior to joining Tutogen, Dr. Crowninshield served twenty-one (21) years in various capacities at Zimmer Holdings, Inc., including President of Zimmer's U.S. operations and most recently as the Company's Chief Scientific Officer. Prior to joining Zimmer, Inc. in 1983, he was a faculty member at the University of Iowa where he led many research projects evaluating the function of total joint implants. He currently holds academic appointments as a professor in the Orthopedic Surgery Department at Rush Medical College in Chicago, Illinois and as an adjunct professor in the College of Engineering of the University of Notre Dame. He holds undergraduate and doctorate degrees from the University of Vermont. He has worked in the orthopedic industry for over twenty (20) years and has extensive experience in the research and development, manufacture, and clinical investigation of orthopedic implants. He has authored more than 100 journal articles, book chapters, and published abstracts in orthopedics and engineering.

Back to top Back to top

Peter F. Gearen, M.D.Peter F. Gearen, M.D.

Peter F. Gearen, M.D. has served as a member of RTI's Board of Directors since February 1998. Dr. Gearen was chief of staff at Shands Hospital at the University of Florida and served as assistant dean of clinical affairs at the University of Florida College of Medicine from 1992 until 1999. He has been an associate professor at the University of Florida College of Medicine since 1993. Dr. Gearen is also a director of Motion Engineering, Inc. He holds a bachelor's degree from Spring Hill College and received his M.D. from Stritch Loyola Medical School.

Back to top Back to top

Udo HenselerUdo Henseler, PH.D.

Udo Henseler, PH.D., has been the President and proprietor of Management Services International , a private business, since 1994. MSI provides business development services for biotechnology and life sciences firms at various stages of their corporate evolution. From 2002 to 2005, Dr. Henseler was the Chief Executive Officer and Chairman of eGene, Inc., a public biotechnology company, and further served as a Director in 2006. Dr. Henseler has over forty (40) years combined global public and private company leadership experience in the biopharmaceutical and life science sectors, including positions as Director, Board Chair, Audit Committee Chair, Chief Executive Officer, Chief Financial Officer, and Executive Vice President. He also taught at the now Peter F. Drucker and Masatoshi Ito Graduate School of Management, CGU.  Dr. Henseler earned his B.A. in Germany, an MBA from Fairleigh Dickinson University in New Jersey, and Master's and Ph.D. degrees from the Claremont Graduate University in Claremont, California. Dr. Henseler is also a Certified Public and Certified Management Accountant and currently serves as Director and Chair of the Audit Committee of Spire Corporation, a public company.

Back to top Back to top

Michael J. OdrichMichael J. Odrich

Michael J. Odrich has served as a member of RTI's Board of Directors since February 1998. Odrich has served as a director of Active Software, Inc. since 1997 and PEMSTAR, Inc. since 1998. Since 1986, he has held various banking positions at Lehman Brothers Inc. Currently he is a managing director, head of the venture capital business and has served as president of Lehman Brothers Venture Associates since 1999. Odrich holds a bachelor's degree from Stanford University and received a masters of business administration degree from Columbia University.

Back to top Back to top

Gregory P. RaineyGregory P. Rainey

Gregory P. Rainey joined RTI's Board of Directors in March 2007. He is the president of CCI Performance Group, a sales and marketing consultant company. Prior to opening CCI Performance Group in 2004, Rainey served 10 years with Stryker Corporation, most recently as vice president of sales for Stryker's Orthopedics Division for four years. Previous to Stryker, Rainey served as director of sales for Joint Medical Corporation, as well as sales positions with U.S. Surgical Corporation. Rainey earned a bachelor's degree in biology from Loyola University

Back to top Back to top

David J. SimpsonDavid J. Simpson

David J. Simpson has served as a member of RTI's Board of Directors since October 2002. Simpson transitioned from his role as vice president, chief financial officer and secretary of Stryker Corporation into the newly created role of executive vice president of the company in 2003. In his new role at Stryker, Simpson has the ability to focus some of his efforts outside the company, including serving as a director for RTI. Simpson earned a bachelor's degree of business administration in accounting and finance from Western Michigan University and attended the advanced management program at Harvard University.

Back to top Back to top

Adrian J.R. SmithAdrian J.R. Smith

Adrian J.R. Smith has been the Chief Executive Officer of The Woolton Group since 1997. He is also the Non-Executive Chairman of Gaming VC S.A., and a Non-Executive Director of Byotrol plc. His business career includes 13 years in the professional services industry and 24 years with two Fortune 500 companies. He has been a Global Managing Partner, Marketing & Communication at Deloitte Touche Tohmatsu, the Chief Executive Officer of Grant Thornton LLP, and a Managing Partner at Arthur Andersen in the early to mid-1990's. He held senior international management roles with Ecolab Inc. and also with Procter & Gamble. He serves on the board of the Education Foundation of Indian River County in Florida.

Back to top Back to top

Web Design by 352 Media Group®. Copyright ©2006 RTI Biologics, Inc. All Rights Reserved. Privacy Policy.